pancreatic cancer patient with abdominal pain. pancreatic cancer, cancer pain, splanchnic nerve neurolysis, neurolysis, celiac plexus neurolysis, abdominal pain
Conditions
Interventions
Percutaneous splanchnic nerve neurolysis under fluoroscopic guidance. Patient keep in prone position. 5 ml of 2% lidocaine was infiltrated before spinal needles 22G were inserted from back to splanchn
Experimental Procedure/Surgery,Experimental Procedure/Surgery
percutaneous splanchnic nerve neurolysis,endoscopic ultrasound guide celiac plexus neurolysis
Sponsors
Ratchadapisek Research Funds
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. age above 18 years 2. Pancreatic cancer patient with numeric rating scale more than 4 from total 10 score 3. patient can make decision to apply the study by themselves and cooperate with the protocol 4. Patient who can follow up for 1 month after procedure
Exclusion criteria
Exclusion criteria: 1. Allergic to agent in study 2. Refuse to join study 3. gut obstruction 3.coagulopathy or use antiplatelet or anticoagulant drug that can not control bleeding risk 4. Pregnancy 5. uncontrol underlying disease sush as uncontrol hypertension, heart failure 6. uncommunicative patient 7. severe systemic infection, local infection in procedure area 8. patient who have pain in other area except abdominal pain 9. Previous percutaneous splanchnic nerve neurolysis or endoscopic ultrasound guide celiac plexus neurolysis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| quality of life 1 week and 1 month after procedure Functional Assessment of Cancer Therapy Hepatobiliary | — |
Secondary
| Measure | Time frame |
|---|---|
| pain score in numeric rating scale 1 week and 1 month after procedure numeric rating scale ,opioid consumption 1 week and 1 month after procedure oral morphine equivalence | — |
Countries
Thailand
Contacts
Public ContactMarvin Thepsoparn
Chulalongkorn hospital
Outcome results
None listed